NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

Open federal opportunities classified under NAICS 541714.

What next? Found opportunities you can win? Start free to bid with AI.

Start free →

Get email alerts for this search

New contracts matching these filters, straight to your inbox. No account needed.

We’ll only email you about matching contracts. Want instant alerts, saved searches and AI proposals? Start free →

Set-asides used in this sector

Small Business8(a)HUBZoneSDVOSBWOSB

About NAICS 541714

Biotechnology R&D — recombinant DNA, cell biology, immunology, and related research. Heavily used by NIH, BARDA, and DoD medical research commands for funded biotech programmes.

Typical award value: $500K – $100M+ per award.

New to this market? Read the in-depth guide: How to win NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) federal contracts →

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

AJ12--Development/Production - Kidney GEC-Specific AAV Vector

Pre-Clinical Models of Infectious Diseases

Alternative Protein Technologies for Military Field Feeding

Pre-Award Synopsis Texas Shield

RFI Lupus Research Program (LRP) Public

NSF X-Labs Initiative - From Sequence to Function

DARPA Surgical Competition (DSC) Second Industry Day

RFI Lupus Research Program (LRP) Public

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)

ARPA-H Emerging Health Innovators (EHI) Initiative

UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)

BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

TIDAL: Target-Induced Droplet Assembly of Ligands

Non-Optical Methods for High Speed Protein Control

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter

Non-Optical Methods for High Speed Protein Control

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

NAWCWD Broad Agency Announcement

BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)